Other studies previously reported a survival benefit for patients with lower expression of XIAP in comparison with patients expressing high levels of XIAP in esophageal squamous cell carcinoma (ESCC) but were not able to reveal a difference in OS in esophageal adenocarcinoma [23]. The gene discussed is XIAP; the disease is esophageal squamous cell carcinoma.